Skip to main content


Clinical Trials

Clinical Trials

Clinical Trials

Janssen Data Transparency Policy

At Janssen, we believe transparency of clinical trial data advances science and medicine, and is in the best interest of the patients who use our pharmaceutical products and providers who prescribe them.

Clinical Trial Data Transparency

To view further details on Janssen's clinical trial data transparency, please visit our Global Clinical Trial Data Transparency site.

Janssen agreement on sharing of clinical trial data with Yale School of Medicine

Janssen Research & Development, LLC, has entered into an agreement with Yale School of Medicine’s Open Data Access (YODA) Project to extend its commitment to sharing clinical trials data to enhance public health and advance science and medicine. Under the agreement, YODA will serve as an independent body to review requests from investigators and physicians seeking access to anonymised clinical trials data from Janssen and make final decisions on data sharing. This is the first time any company has collaborated with a completely independent third party to review and make decisions regarding every request for clinical data. In addition to sharing data from Janssen’s pharmaceutical product clinical trials through the agreement with YODA, Johnson & Johnson is also committed to sharing data from clinical trials of its medical device and consumer products.

Find out more.

We support the overall principles of greater clinical trial data transparency, including registration and disclosure of clinical trial results in external registries, publication of results in peer reviewed journals, and sharing of Clinical Study Reports (CSRs). 



Date of Preparation: June 2021 | Item Code: CP-242872